MELVILLE, N.Y., Sept. 17,
2019 /PRNewswire/ -- Expanding the company's lineup of eye-care
product offerings, Canon U.S.A.,
Inc., a leader in digital imaging solutions, is pleased to announce
the new intuitive, user-friendly Xephilio OCT-A1 Optical Coherence
Tomography device from Canon Inc. This device features automated
acquisition functionality, which makes it easy to use, allowing
healthcare professionals to obtain high-quality reproducible scans
and images. The Xephilio OCT-A1 Optical Coherence Tomography device
has received FDA 510(k) clearance for sale in the United States of
America1.
The Xephilio OCT-A1 Optical Coherence Tomography device,
together with the required RX Capture software, computer and LCD
monitor (collectively, the "Xephilio OCT-A1 System"), is an optical
coherence tomography system indicated for the in-vivo imaging and
measurement of the retina, retinal nerve fiber layer, and optic
disc. In addition, it is a tool to aid in the diagnosis and
management of retinal diseases by a clinician. The Xephilio
OCT-A1 System has a scanning speed of 70,000 A-scans per second
with optical depth resolution of approximately three microns. With
its integrated scanning laser ophthalmoscopic real-time retinal
tracking technology, the Xephilio OCT A-1 System automatically
retains the scan position and scan protocol for each patient from
one exam to the next, eliminating the need for manual adjustment by
the operator. A mouse-controlled, three-click operation is
used to engage the automated alignment, tracking, and acquisition
of high-quality images and scans. To help create a positive,
effective user experience, the positioning of the components of the
Xephilio OCT-A1 System can allow for the operator and patient to
sit side-by-side.
"Designed to meet the needs of customers, the Xephilio OCT-A1
System is a user-friendly solution designed to help healthcare
professionals capture high-resolution images and scans with ease
and efficiency," says Tsuneo Imai,
vice president and general manager, Healthcare Solutions, Business
Information Communications Group, Canon U.S.A., Inc. "Canon U.S.A. is proud to make the Xephilio OCT-A1
System available to its customers."
The Xephilio OCT-A1 System is versatile and can be used by
healthcare professionals in a variety of settings, including
ophthalmology private practices, optometric schools, telehealth,
and telemedicine primary care providers2. In addition,
the Xephilio OCT-A1 System can also help healthcare professionals
identify the disease state and monitor disease conditions before
and after treatments in ophthalmology private practices, retinal
clinics, teaching hospitals, and institutions. For optometry
practices and optometric schools, this System can aid optometry
students in recognizing diseases and conditions in primary care,
while also showing them how to detect conditions prior to and after
referral to ophthalmology practitioners.
"The Xephilio OCT-A1 System with its easy-to-use functions
(three mouse clicks to capture any OCT image through a minimum of
3.0 mm pupil) is a great system for medical and optometry students
as it delivers high-quality imagery with approximately three micron
optical depth resolution and 70,000 scans," says Ben Szirth, Ph.D.,
Director, Tele-Ocular Program, Institute of Ophthalmology and
Visual Science, New Jersey Medical School3. "It is this
type of system that may assist students preparing to enter the
competitive field of eye care."
The Xephilio OCT-A1 System will be showcased in the Canon Booth
#MS9048 at Vision Expo West, taking place from September 19-21, 2019 at the Sands Expo &
Convention Center in Las Vegas. In
addition to the Xephilio OCT-A1 System, this booth will also
exhibit the CR-2 PLUS AF Non-Mydriatic Retinal Camera.
For more information, please call (800) 970-7227, or visit
usa.canon.com/eye-care.
About Canon U.S.A.,
Inc.
Canon U.S.A., Inc. is
a leading provider of consumer, business-to-business, and
industrial digital imaging solutions to the United States and to Latin America and the Caribbean markets. With approximately
$36 billion in global revenue, its
parent company, Canon Inc. (NYSE:CAJ), ranks third overall in U.S.
patents granted in 2018† and is one of Fortune
Magazine's World's Most Admired Companies in 2018.
Canon U.S.A. is dedicated to its
Kyosei philosophy of social and environmental
responsibility. To keep apprised of the latest news from Canon
U.S.A., sign up for the Company's
RSS news feed by visiting www.usa.canon.com/rss and
follow us on Twitter @CanonUSA.
†Based on weekly patent counts issued by United
States Patent and Trademark Office.
1 FDA clearance does not in any way denote FDA
approval of this device.
2 Requires both senders and receivers to have
internet access and the recipient to have an operating system that
can open jpeg or pdf files.
3 Ben Szirth, Ph.D., is a paid consultant who
provides advisory and consulting services to Canon
U.S.A. on a regular basis.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/canon-xephilio-oct-a1-optical-coherence-tomography-device-receives-fda-510k-clearance-300919934.html
SOURCE Canon U.S.A., Inc.